Advent Life Sciences LLP
adventls.com Direct investor
Advent Life Sciences is a venture capital firm focused on building innovative life sciences businesses in the UK, Europe, and the USA. It invests in early and mid-stage companies with a first-in-class or best-in-class approach, primarily in drug discovery, med tech, enabling technologies, and vaccines.
Advent Life Sciences LLP is a venture capital firm headquartered in London, United Kingdom, founded in 2006. It invests directly in companies, from seed to Series B, in life Sciences, drug discovery, med tech and enabling technologies. 50 portfolio companies, as it reports.
“We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach.”
— Advent Life Sciences LLP, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- London, United Kingdom
- Invests in
- UK, Europe, USA
- Sectors
- Life Sciences, drug discovery, med tech, enabling technologies, vaccines
- Founded
- 2006
- Portfolio
- 50 companies
Team, as Advent Life Sciences LLP publishes it
- Shahzad Malik General Partner
- Raj Parekh General Partner
- Kaasim Mahmood General Partner
- Dominic Schmidt General Partner
- Satish Jindal General Partner
- Katrine Bosley Venture Partner
- Don Drakeman Venture Partner
- Alain Huriez Venture Partner
- Majid Kazmi Clinical Advisor
- Roy Lobb Venture Partner
- Jon Moore Operating Partner
- Fraser Murray Head of Scientific Evaluation
Names and roles exactly as listed on adventls.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 71 co-investors found.
- OrbiMed 4 shared companies: aurabiosciences.com, acutusmedical.com, emergentbiosolutions.com, nerretherapeutics.com
- Aisling Capital Management LP 2 shared companies: f2g.com, infi.com
- Longitude Capital 2 shared companies: nalumed.com, axonics.com
- Runway Growth Capital LLC 2 shared companies: nalumed.com, moximed.com
- General Catalyst 2 shared companies: aura.com, beacon.com
- Cambridge Innovation Capital 2 shared companies: epitopea.com, centessa.com
- Foresite Capital 2 shared companies: centessa.com, aurabiosciences.com
- Hanaco Ventures 1 shared company: curve.com
- Mouro Capital 1 shared company: curve.com
- Outward VC 1 shared company: curve.com
and 61 more — the graph.
Where this comes from
Every fact above was read from a page Advent Life Sciences LLP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://adventls.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, founded, status
- https://adventls.com/portfolio/portfolio_count
- https://adventls.com/team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 2670 · added 2026-09-03 · link last verified 2026-09-06 · confidence high
Similar investors
- AbingworthVenture capital · Seed – Series C+ · London, United Kingdom
- Monograph Capital Advisors (UK) LLPVenture capital · Seed – Series B · London, United Kingdom
- Parkwalk AdvisorsVenture capital · Seed – Series C+ · London, United Kingdom
- 2150Venture capital · London, United Kingdom
- 4BIO Partners LLPVenture capital · Seed – Series A · London, United Kingdom
- Active PartnersVenture capital · London, United Kingdom